| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM200001273420402 |
| P698 | PubMed publication ID | 10648764 |
| P50 | author | David K. Shay | Q38641565 |
| P2093 | author name string | Davis RL | |
| Fukuda K | |||
| Black S | |||
| DeStefano F | |||
| Kramarz P | |||
| Thompson WW | |||
| Shinefield H | |||
| Izurieta HS | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hospitalization | Q3140971 |
| respiratory disease | Q3286546 | ||
| P304 | page(s) | 232-239 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Influenza and the rates of hospitalization for respiratory disease among infants and young children | |
| P478 | volume | 342 |
| Q30395222 | 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. |
| Q57101803 | 2009 pandemic influenza a vaccination of pregnant women--King County, Washington State, 2009-2010 |
| Q42909963 | A Comprehensive Surveillance of Adamantane Resistance among Human Influenza a Virus Isolated from Mainland China between 1956 and 2009 |
| Q43175321 | A four-stage strategy to reduce childhood pneumonia-related mortality by 2015 and beyond |
| Q30398268 | A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). |
| Q64132044 | A personnel time-motion study of intranasal influenza vaccination in healthy children |
| Q33575989 | A prospective study on ambulatory care provided by primary care pediatricians during influenza season |
| Q43210853 | A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season |
| Q37530395 | A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age |
| Q33940730 | A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection |
| Q73034690 | A study of influenza and influenza-related complications among children in a large US health insurance plan database |
| Q47727515 | Accuracy of clinical diagnosis of influenza in outpatient children |
| Q30391956 | Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice |
| Q37885249 | Admission diagnoses of children 0-16 years of age hospitalized with influenza |
| Q34789319 | Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice. |
| Q42773890 | Age-based human influenza A virus (H5N1) infection patterns, Egypt |
| Q37727183 | Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea. |
| Q37173332 | Antibody responses after inactivated influenza vaccine in young children |
| Q35661210 | Are we ready for universal influenza vaccination in paediatrics? |
| Q34687309 | Assessing parents' knowledge and attitudes towards seasonal influenza vaccination of children before and after a seasonal influenza vaccination effectiveness study in low-income urban and rural Kenya, 2010-2011. |
| Q30847472 | Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review |
| Q41978931 | Association between respiratory viruses and asthma exacerbations |
| Q44792288 | Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children |
| Q40767563 | Attitudes and perceptions among the pediatric health care providers toward influenza vaccination in Qatar: A cross-sectional study |
| Q46054583 | Availability of trivalent inactivated influenza vaccine to parents of neonatal intensive care unit patients and its effect on the healthcare worker vaccination rate |
| Q36342730 | Bench-to-bedside review: Paediatric viral lower respiratory tract disease necessitating mechanical ventilation--should we use exogenous surfactant? |
| Q37976536 | Benefits to mother and child of influenza vaccination during pregnancy |
| Q36458508 | Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua |
| Q36377400 | Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia |
| Q34501076 | Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis. |
| Q35277693 | Burden of influenza in healthy children and their households. |
| Q35768280 | Burden of influenza-related hospitalizations among children with sickle cell disease |
| Q89851557 | Characterisation of respiratory syncytial virus activity in children and adults presenting with acute respiratory illness at primary care clinics in Singapore, 2014-2018 |
| Q33630054 | Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study |
| Q35057084 | Cigarette smoke extract suppresses the RIG-I-initiated innate immune response to influenza virus in the human lung |
| Q39568695 | Circulating Influenza Virus and Adverse Pregnancy Outcomes: A Time-Series Study |
| Q64134362 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
| Q59397173 | Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years |
| Q40101689 | Clinical and epidemiological features of respiratory virus infections in preschool children over two consecutive influenza seasons in southern Brazil |
| Q34047266 | Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. |
| Q30411871 | Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza |
| Q30409532 | Clinical characteristics and outcomes among pediatric patients hospitalized with pandemic influenza A/H1N1 2009 infection. |
| Q31166045 | Clinical data on Fluarix: an inactivated split seasonal influenza vaccine |
| Q30394602 | Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients |
| Q37780548 | Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines |
| Q39946796 | Cocooning: Influenza Vaccine for Parents and Caregivers in an Urban, Pediatric Medical Home |
| Q51729193 | Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. |
| Q35728567 | Cold-adapted, live attenuated influenza vaccine |
| Q30891396 | Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis |
| Q36295456 | Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects |
| Q33319642 | Comparing estimates of influenza-associated hospitalization and death among adults with congestive heart failure based on how influenza season is defined |
| Q40535330 | Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents |
| Q30429174 | Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia. |
| Q39413153 | Comparison of polyurethane foam to nylon flocked swabs for collection of secretions from the anterior nares in performance of a rapid influenza virus antigen test in a pediatric emergency department |
| Q37122305 | Complications of viral influenza |
| Q34519847 | Contemporary approach to the emergency department management of pediatric asthma |
| Q37331059 | Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis |
| Q35733952 | Control of influenza |
| Q30381426 | Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial |
| Q37054595 | Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles |
| Q37912501 | Cost-effectiveness and socio-economic aspects of childhood influenza vaccination |
| Q48607912 | Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. |
| Q40111439 | Cost-effectiveness of a new internet-based monitoring tool for neonatal post-discharge home care |
| Q59505997 | Cost-effectiveness of influenza vaccination of healthy children |
| Q53559924 | Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. |
| Q34493910 | Coverage and parental perceptions of influenza vaccination among parents of children aged 6 to 23 months in Hong Kong |
| Q58617949 | DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial |
| Q45280117 | Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program |
| Q92003834 | Demographic Determinants of Influenza Vaccination and Infection, Brazos County, Texas, 2017 |
| Q30445738 | Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. |
| Q33735482 | Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction |
| Q36630178 | Determination of Appropriate Dosing of Influenza Drugs in Pediatric Patients |
| Q33883224 | Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children |
| Q33588926 | Dispelling myths held by parents about the influenza vaccine |
| Q93488361 | Dissiper les mythes entretenus par les parents au sujet du vaccin contre l’influenza |
| Q60286996 | Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children |
| Q57457676 | Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: a randomized controlled trial |
| Q43887160 | Effect of influenza vaccination on hospitalizations in persons aged 50 years and older |
| Q36252888 | Effect of rapid influenza testing on the clinical management of paediatric influenza |
| Q37912505 | Effectiveness and safety of influenza vaccination in children: European perspective |
| Q33646793 | Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy |
| Q92134349 | Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings |
| Q40342526 | Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study |
| Q43823774 | Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households |
| Q42228543 | Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. |
| Q43171454 | Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010-2011. |
| Q40474518 | Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study. |
| Q92616679 | Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis |
| Q98195923 | Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3-17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 season |
| Q53892487 | Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. |
| Q37486917 | Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine |
| Q30425960 | Employer-incurred health care costs and productivity losses associated with influenza |
| Q39308116 | Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children |
| Q30408522 | Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine |
| Q57490857 | Epidemiology and Immune Pathogenesis of Viral Sepsis |
| Q30410172 | Epidemiology and clinical presentation of pandemic influenza A (H1N1) among hospitalized children in Kuwait |
| Q43175183 | Epidemiology and outcomes of hospitalization of influenza in the cancer population in Taiwan |
| Q43490574 | Epidemiology and outcomes of serious influenza-related infections in the cancer population |
| Q35566693 | Epidemiology and virology of acute respiratory infections during the first year of life: a birth cohort study in Vietnam |
| Q83381407 | Epidemiology of influenza |
| Q30358746 | Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. |
| Q36759964 | Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign |
| Q92202554 | Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15 |
| Q30362593 | Estimated paediatric mortality associated with influenza virus infections, United States, 2003-2010. |
| Q37179273 | Estimates of US influenza-associated deaths made using four different methods |
| Q90544416 | Estimating Influenza-associated Mortality in Korea: The 2009-2016 Seasons |
| Q93075125 | Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data |
| Q36403778 | Estimating influenza hospitalizations among children |
| Q35476858 | Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons |
| Q30942595 | Estimating influenza-related hospital admissions in older people from GP consultation data |
| Q41881421 | Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test. |
| Q21136144 | Evaluation of targeted influenza vaccination strategies via population modeling |
| Q44767209 | Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months |
| Q35669496 | Every nose counts: a new influenza vaccine for all healthy schoolchildren? |
| Q39957532 | Exploring pregnant women's views on influenza vaccination and educational text messages |
| Q33909037 | Exposure to infections and risk of leukemia in young children |
| Q34432027 | Factors influencing childhood influenza immunization. |
| Q79850461 | Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months |
| Q30410488 | Features associated with severe disease in hospitalized children with 2009 influenza A (H1N1) infection at a university hospital in Riyadh, Saudi Arabia. |
| Q95811931 | Febrile respiratory tract illness in a 3-month old infant |
| Q34706374 | Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors |
| Q40358535 | Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine |
| Q33644969 | Get the vaccine not the 'flu: Gearing up for influenza vaccine campaign 2000. |
| Q37955413 | Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis |
| Q40427971 | Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents. |
| Q43177458 | Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children |
| Q44816877 | High costs of influenza: Direct medical costs of influenza disease in young children |
| Q35906893 | Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. |
| Q42619323 | ICD-9 codes for identifying influenza hospitalizations in children |
| Q34099150 | Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system |
| Q37232946 | Immune dysregulation in severe influenza |
| Q47564024 | Immunization Practices of U.S. Obstetrician/Gynecologists for Pregnant Patients |
| Q36144996 | Immunizations in the United States: a rite of passage |
| Q33609256 | Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial. |
| Q79902462 | Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years |
| Q84066589 | Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial |
| Q36252900 | Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine |
| Q34260819 | Immunogenicity of the trivalent inactivated influenza vaccine in young children less than 4 years of age, with a focus on age and baseline antibodies |
| Q34960945 | Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants |
| Q24187227 | Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes |
| Q24202538 | Impact of haemophilus influenza type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes |
| Q35641291 | Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women |
| Q39963590 | Impact of influenza infection on children's hospital admissions during two seasons in Athens, Greece |
| Q64117364 | Impact of influenza on hospitalization rates in children with a range of chronic lung diseases |
| Q35556590 | Impact of influenza on young children and the shaping of United States influenza vaccine policy |
| Q35036946 | Impact of maternal immunization on influenza hospitalizations in infants |
| Q38978360 | Impact of vaccination on influenza mortality in children <5years old in Mexico |
| Q57103282 | Impact of weather factors on influenza hospitalization across different age groups in subtropical Hong Kong |
| Q30327565 | Implications of pandemic influenza for bioterrorism response. |
| Q81151870 | Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination |
| Q36767404 | Improving influenza immunisation for high-risk children and adolescents |
| Q40378753 | Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification |
| Q81235322 | Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season |
| Q34301431 | Inactivated influenza virus vaccines in children |
| Q37091628 | Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons |
| Q40052471 | Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review |
| Q35819735 | Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina |
| Q40184119 | Increased risk of influenza among vaccinated adults who are obese |
| Q30405770 | Indoor exposure to particulate matter and age at first acute lower respiratory infection in a low-income urban community in Bangladesh |
| Q30391418 | Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination |
| Q37284961 | Infectious diseases and vaccine sciences: strategic directions |
| Q57028463 | Influenza |
| Q57116936 | Influenza |
| Q82141762 | Influenza |
| Q30421504 | Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients |
| Q40567104 | Influenza A and B virus infections in children |
| Q40169142 | Influenza A and respiratory syncytial virus hospital burden in young children in East London |
| Q56880145 | Influenza Vaccination in Children with Asthma |
| Q40611833 | Influenza a in young children with suspected respiratory syncytial virus infection |
| Q38068065 | Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy |
| Q45402280 | Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains |
| Q35283578 | Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps? |
| Q30329366 | Influenza diagnosis and treatment: a view from clinical practice. |
| Q30387836 | Influenza epidemiology among hospitalized children in Stockholm, Sweden 1998-2014. |
| Q40059792 | Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group |
| Q40587195 | Influenza immunization during pregnancy: Benefits for mother and infant |
| Q47331095 | Influenza immunization policies: Which could be the main reasons for differences among countries? |
| Q79279117 | Influenza in children |
| Q47449576 | Influenza in children: the German perspective |
| Q36153722 | Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain |
| Q36153678 | Influenza related hospitalisations in Sydney, New South Wales, Australia. |
| Q81559635 | Influenza vaccination among healthcare workers in a university children's hospital |
| Q39821332 | Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study |
| Q35158303 | Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013 |
| Q30411868 | Influenza vaccination coverage rate in children: reasons for a failure and how to go forward |
| Q40096935 | Influenza vaccination in paediatric nurses: cross-sectional study of coverage, refusal, and factors in acceptance |
| Q30350930 | Influenza vaccination in the elderly: impact on hospitalisation and mortality. |
| Q50778631 | Influenza vaccination of healthcare workers in the United States, 1989-2002. |
| Q37481353 | Influenza vaccination options to prevent hospitalization. |
| Q46084267 | Influenza vaccination rates of expectant parents with neonatal intensive care admission |
| Q36136123 | Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons |
| Q83011818 | Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study |
| Q43175567 | Influenza vaccine effectiveness and confounding factors among young children |
| Q57560041 | Influenza vaccine in healthy children: a meta-analysis |
| Q36383823 | Influenza vaccine in patients with asthma |
| Q30363575 | Influenza vaccine programs and pregnancy: new Canadian evidence for immunization. |
| Q41934389 | Influenza vaccine use to protect healthy children: A debated topic |
| Q39737985 | Influenza vaccine: immunization rates, knowledge, and attitudes of resident physicians in an urban teaching hospital |
| Q34218554 | Influenza vaccine: issues and opportunities |
| Q34189122 | Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. |
| Q30385118 | Influenza vaccines: from surveillance through production to protection. |
| Q42177564 | Influenza virus surveillance among young children in São Paulo, Brazil: the impact of vaccination |
| Q57384999 | Influenza- and RSV-associated hospitalizations among adults |
| Q25256617 | Influenza-associated hospitalization in a subtropical city |
| Q39601092 | Influenza-associated mortality in Hong Kong |
| Q37726768 | Influenza-related healthcare visits, hospital admissions, and direct medical costs for all children aged 2 to 17 years in a defined Swedish region, monitored for 7 years |
| Q43614574 | Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001-June 2004). |
| Q34785408 | Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. |
| Q56762471 | Influenza-related morbidity and mortality among children in developed and developing countries |
| Q30235246 | Influenza. |
| Q73235290 | Influenza: New Insights Into an Old Disease |
| Q30405546 | Influenza: clinical symptoms, diagnostics and therapy |
| Q37812615 | Influvac, a trivalent inactivated subunit influenza vaccine. |
| Q37463506 | Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model |
| Q27489605 | Innate immunity to influenza virus: implications for future therapy |
| Q30406695 | Inpatient capacity at children's hospitals during pandemic (H1N1) 2009 outbreak, United States |
| Q37812124 | Intanza®: a new intradermal vaccine for seasonal influenza |
| Q33556138 | Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-κB activity through promoting TRAF6 ubiquitination |
| Q38646313 | Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: A systematic review. |
| Q45397635 | Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? |
| Q36360529 | Is influenza vaccination in asthmatic children helpful? |
| Q79081651 | Is influenza vaccination necessary in children with asthma? |
| Q34606237 | Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review |
| Q38416489 | Live attenuated influenza vaccine tetravalent: a clinical review |
| Q34337076 | Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial |
| Q34324982 | Live attenuated influenza virus vaccines: new options for the prevention of influenza |
| Q57451108 | Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma |
| Q54426252 | Longitudinal clearance of seasonal influenza A viral RNA measured by real-time polymerase chain reaction in patients identified at a hospital emergency department. |
| Q56791521 | Low reactogenicity of the virosomal subunit influenza vaccine in healthy children without risk factors |
| Q37706610 | MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk |
| Q33836970 | Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization |
| Q30386781 | Maternal vaccination for the prevention of influenza: current status and hopes for the future. |
| Q34321386 | Model selection in time series studies of influenza-associated mortality |
| Q33893785 | Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends |
| Q30399490 | Mortality attributable to pandemic influenza A (H1N1) 2009 in San Luis Potosí, Mexico |
| Q37559647 | Mucosal vaccines: novel advances in technology and delivery |
| Q91105923 | Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection |
| Q35586896 | Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice |
| Q37162875 | Neonatal natural killer cell function: relevance to antiviral immune defense |
| Q24243136 | Neuraminidase inhibitors for preventing and treating influenza in children |
| Q24247957 | Neuraminidase inhibitors for preventing and treating influenza in children |
| Q24203875 | Neuraminidase inhibitors for preventing and treating influenza in children |
| Q24200222 | Neuraminidase inhibitors for preventing and treating influenza in children (published trials only) |
| Q35627874 | Neuraminidase inhibitors in patients with underlying airways disease |
| Q35045959 | Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy |
| Q30350342 | Novel strategies for prevention and treatment of influenza. |
| Q30405999 | Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study |
| Q64134866 | Obstetrician-Gynecologists' Strategies to Address Vaccine Refusal Among Pregnant Women |
| Q47598374 | Optimizing long-term care by administration of influenza vaccine to parents of NICU patients |
| Q36584645 | Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza |
| Q37828363 | Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak |
| Q35124715 | Paediatric community-acquired pneumonia: current concept in pharmacological control |
| Q34886641 | Parental perspectives on influenza vaccination among children with asthma |
| Q35880283 | Pediatric influenza prevention and control |
| Q37086279 | Pediatric influenza-associated myositis - Nebraska, 2001-2007. |
| Q40362838 | Performance of rapid influenza testing in hospitalized children |
| Q44544248 | Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years |
| Q43177595 | Poor immune responses to influenza vaccination in infants |
| Q51980197 | Population-wide benefits of routine vaccination of children against influenza. |
| Q36903940 | Practice and Child Characteristics Associated With Influenza Vaccine Uptake in Young Children |
| Q28187693 | Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants |
| Q36486569 | Pregnant women's attitudes toward influenza vaccination while breastfeeding |
| Q83571165 | Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy |
| Q26773220 | Prenatal Alcohol Exposure and the Developing Immune System |
| Q37848838 | Present and future of influenza prevention in pediatrics |
| Q30375316 | Prevalence and associated factors of seasonal influenza vaccination among 24- to 59-month-old children in Hong Kong. |
| Q30398281 | Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands |
| Q37017252 | Prevention and control of influenza in persons with chronic obstructive pulmonary disease |
| Q35943670 | Prevention of influenza in the general population |
| Q30418041 | Prevention of novel influenza infection in newborns in hospital settings: considerations and strategies during the 2009 H1N1 pandemic |
| Q34342190 | Prevention of respiratory syncytial virus infections |
| Q33953754 | Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review |
| Q47925908 | Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). |
| Q33588918 | Protecting young babies from influenza |
| Q45324173 | Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity |
| Q30396288 | Protective essential oil attenuates influenza virus infection: An in vitro study in MDCK cells |
| Q50234343 | Protéger les jeunes bébés contre la grippe |
| Q39204869 | Quantifying differences in the epidemic curves from three influenza surveillance systems: a nonlinear regression analysis |
| Q39625974 | QuickVue influenza test for rapid detection of influenza A and B viruses in a pediatric population |
| Q40060505 | RIG-I overexpression decreases mortality of cigarette smoke exposed mice during influenza A virus infection |
| Q30409553 | Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis. |
| Q43626562 | Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children |
| Q36187779 | Rationale and design of the prevention of respiratory infections and management in children (PRIMAKid) study: a randomized controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with |
| Q79442793 | Rationale for the administration of acellular pertussis vaccine to parents of infants in the neonatal intensive care unit |
| Q94352812 | Recommandations quant à l’usage du vaccin contre l’influenza chez les enfants |
| Q84354864 | Recommendations for the use of influenza vaccine for children |
| Q37496797 | Reducing the burden of influenza-associated complications with antiviral therapy |
| Q36145000 | Reducing the impact of viral respiratory infections in children |
| Q36369980 | Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury |
| Q36030806 | Relative impact of influenza and respiratory syncytial virus in young children |
| Q30422342 | Renal complications of seasonal and pandemic influenza A virus infections |
| Q45725286 | Renal involvement in children with influenza A virus infection. |
| Q30399595 | Resource burden at children's hospitals experiencing surge volumes during the spring 2009 H1N1 influenza pandemic |
| Q37383578 | Respiratory syncytial virus outbreak in a long-term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real-time detection methods |
| Q37331088 | Retrospective review of factors associated with severe hospitalised community-acquired influenza in a tertiary paediatric hospital in South Australia |
| Q36487512 | Rhino/enteroviruses in hospitalized children: a comparison to influenza viruses. |
| Q30420381 | Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*. |
| Q35875663 | Role of influenza vaccine for healthy children in the US. |
| Q35268325 | Routine influenza vaccination for healthy children--old concept, new technologies |
| Q82481907 | Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens |
| Q35268453 | Safety and immunogenicity of a paediatric presentation of an influenza vaccine |
| Q30395173 | Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults |
| Q37086288 | Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children |
| Q83876420 | Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer |
| Q36990293 | Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. |
| Q42186191 | Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation |
| Q51176333 | School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: an ecological study. |
| Q91910138 | Seasonal Human Influenza: Treatment Options |
| Q30377815 | Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems |
| Q30419114 | Seasonal and pandemic influenza: an overview with pediatric focus |
| Q48585293 | Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America |
| Q30402411 | Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. |
| Q40740131 | Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China |
| Q34146066 | Seasonal influenza vaccine effectiveness among children aged 6 to 59 months in southern China |
| Q37912499 | Seasonal influenza: the burden of disease in children |
| Q34194336 | Serologic assays for influenza surveillance, diagnosis and vaccine evaluation |
| Q51128149 | Seroprevalence of influenza A and B in German infants and adolescents. |
| Q38630141 | Seroprevalence of influenza A and B viruses among unvaccinated children in the United Arab Emirates: a cross-sectional study |
| Q39454744 | Severe influenza in children: incidence and risk factors |
| Q36348822 | Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. |
| Q34073615 | Signs and symptoms predicting influenza in children: a matched case-control analysis of prospectively collected clinical data |
| Q40548573 | Socioeconomic impact of influenza on healthy children and their families |
| Q46446436 | Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. |
| Q38448647 | Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? |
| Q30205195 | Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses |
| Q38086165 | Targeting the skin for microneedle delivery of influenza vaccine |
| Q59335181 | Temporal analysis of determinants for respiratory emergency department visits in a large German hospital |
| Q40991359 | The ESPID/ESWI Joint Symposium - A strong vote for universal influenza vaccination in children in Europe |
| Q56762449 | The Epidemiology of Influenza and Its Control |
| Q56505186 | The Impact of IgG transplacental transfer on early life immunity |
| Q22242904 | The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America |
| Q29030744 | The annual impact of seasonal influenza in the US: Measuring disease burden and costs |
| Q31031150 | The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: an analysis of routine surveillance data |
| Q40662861 | The battle against influenza: The role of neuraminidase inhibitors in children |
| Q41835008 | The battle against influenza: The role of neuraminidase inhibitors in children. |
| Q90684309 | The burden and clinical manifestation of hospitalized influenza among different pediatric age-groups in the tropics |
| Q50132581 | The burden of influenza-like illness in the US workforce |
| Q34938343 | The burden of respiratory syncytial virus infection in young children |
| Q30430303 | The burden of seasonal and pandemic influenza in infants and children |
| Q34169126 | The common cold |
| Q36493927 | The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children |
| Q40343235 | The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia. |
| Q31148484 | The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study |
| Q33547664 | The epidemiology of hospitalized influenza in children, a two year population-based study in the People's Republic of China |
| Q30432137 | The impact of influenza and respiratory syncytial virus on hospitalizations for lower respiratory tract infections in young children: Slovenia, 2006-2011. |
| Q45709846 | The impact of influenza viruses on hospitalizations in infants younger than two years old during epidemics of respiratory syncytial virus infection |
| Q35065146 | The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. |
| Q36559785 | The impact of national vaccination policy changes on influenza incidence in the Netherlands |
| Q30363019 | The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children. |
| Q61835831 | The impact of timing of maternal influenza immunization on infant antibody levels at birth |
| Q37946432 | The ins and outs of universal childhood influenza vaccination |
| Q44704491 | The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization |
| Q28743825 | The population impact of a large school-based influenza vaccination campaign |
| Q45324551 | The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review |
| Q31148192 | The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons. |
| Q30355388 | The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. |
| Q37678409 | The virosomal adjuvanted influenza vaccine |
| Q40073913 | Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial |
| Q36084849 | Trends in asthma prevalence, hospitalization risk, and inhaled corticosteroid use among alaska native and nonnative medicaid recipients younger than 20 years |
| Q84170208 | Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? |
| Q82074842 | Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters |
| Q37135432 | Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia |
| Q34511035 | Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine |
| Q40093500 | Urgent challenges in implementing live attenuated influenza vaccine |
| Q30377041 | Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. |
| Q43820942 | Vaccination during pregnancy to protect infants against influenza: why and why not? |
| Q33728238 | Vaccination updates |
| Q36964157 | Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons |
| Q39170352 | Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy. |
| Q24243174 | Vaccines for preventing influenza in healthy children |
| Q24244954 | Vaccines for preventing influenza in healthy children |
| Q24201525 | Vaccines for preventing influenza in healthy children |
| Q47638511 | Vaccines for preventing influenza in healthy children |
| Q57272289 | Vaccines for preventing influenza in healthy children |
| Q35604292 | Vaccines in pregnancy: a review of their importance in Brazil |
| Q33849000 | Validation of statistical models for estimating hospitalization associated with influenza and other respiratory viruses |
| Q37947937 | Validity of parental report of influenza vaccination in young children seeking medical care |
| Q24805596 | Values for preventing influenza-related morbidity and vaccine adverse events in children |
| Q40751509 | Viral Infections in Children in the 2014/2015 Epidemic Season in Poland. |
| Q36830101 | Viral aetiology in adults with acute upper respiratory tract infection in Jinan, Northern China |
| Q33859448 | Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004-2008. |
| Q34731401 | Viral etiology of acute respiratory infection in Gansu Province, China, 2011. |
| Q33815604 | Viral lower respiratory tract infection in infants and young children |
| Q35023496 | Virosome influenza vaccine in children. |
| Q33811438 | Viruses and asthma |
| Q36823154 | What is the role of virus vaccination in patients with asthma? |
| Q26796334 | Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review |
| Q43176395 | Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy |
| Q35561524 | Work factors as predictors of sickness absence attributed to airway infections; a three month prospective study of nurses' aides |
| Q57109445 | Yearly influenza vaccinations: a double-edged sword? |
| Q73571883 | [Infant bronchiolitis: prevention of transmission and long-term respiratory morbidity] |
| Q80025027 | [Infection by influenza virus in childhood: a call for broader influenza vaccination] |
| Q73181776 | [Prevention of influenza in children] |
Search more.